Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 5
2013 6
2014 6
2015 6
2016 3
2017 1
2018 1
2019 1
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial.
Costi S, Soleimani L, Glasgow A, Brallier J, Spivack J, Schwartz J, Levitch CF, Richards S, Hoch M, Stade EC, Welch A, Collins KA, Feder A, Iosifescu DV, Charney DS, Murrough JW. Costi S, et al. Neuropsychopharmacology. 2019 Sep;44(10):1812-1819. doi: 10.1038/s41386-019-0365-0. Epub 2019 Mar 11. Neuropsychopharmacology. 2019. PMID: 30858518 Free PMC article. Clinical Trial.
Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder.
Tan A, Costi S, Morris LS, Van Dam NT, Kautz M, Whitton AE, Friedman AK, Collins KA, Ahle G, Chadha N, Do B, Pizzagalli DA, Iosifescu DV, Nestler EJ, Han MH, Murrough JW. Tan A, et al. Mol Psychiatry. 2020 Jun;25(6):1323-1333. doi: 10.1038/s41380-018-0283-2. Epub 2018 Nov 1. Mol Psychiatry. 2020. PMID: 30385872 Free PMC article. Clinical Trial.
Ketamine Treatment and Global Brain Connectivity in Major Depression.
Abdallah CG, Averill LA, Collins KA, Geha P, Schwartz J, Averill C, DeWilde KE, Wong E, Anticevic A, Tang CY, Iosifescu DV, Charney DS, Murrough JW. Abdallah CG, et al. Neuropsychopharmacology. 2017 May;42(6):1210-1219. doi: 10.1038/npp.2016.186. Epub 2016 Sep 8. Neuropsychopharmacology. 2017. PMID: 27604566 Free PMC article.
"Does Ketamine Have Rapid Anti-Suicidal Ideation Effects?".
Soleimani L, Welch A, Murrough JW. Soleimani L, et al. Curr Treat Options Psychiatry. 2015 Dec;2(4):383-393. doi: 10.1007/s40501-015-0065-2. Epub 2015 Oct 16. Curr Treat Options Psychiatry. 2015. PMID: 26918229 Free PMC article. No abstract available.
Emerging drugs for the treatment of anxiety.
Murrough JW, Yaqubi S, Sayed S, Charney DS. Murrough JW, et al. Expert Opin Emerg Drugs. 2015 Sep;20(3):393-406. doi: 10.1517/14728214.2015.1049996. Epub 2015 Jun 1. Expert Opin Emerg Drugs. 2015. PMID: 26012843 Free PMC article. Review.
26 results